Success Metrics

Clinical Success Rate

66.7%

Based on 2 completed trials

Completion Rate

67%(2/3)

Active Trials

0(0%)

Results Posted

100%(2 trials)

Terminated

1(25%)

Phase Distribution

Ph not_applicable

75%

Phase Distribution

Early Stage

Mid Stage

Late Stage

Phase Distribution3 total trials

N/ANon-phased studies

3(100.0%)

Highest Phase Reached

Unknown

Trial Status & Enrollment

Completion Rate

50.0%

2 of 4 finished

Non-Completion Rate

50.0%

2 ended early

Currently Active

trials recruiting

Total Trials

all time

Status Distribution

Completed(2)

Terminated(2)

Detailed Status

Completed2

Terminated1

Withdrawn1

Development Timeline

Analytics

Development Status

Total Trials

Active

Success Rate

66.7%

Most Advanced

N/A

Trials by Phase

N/A3 (100.0%)

Trials by Status

terminated125%

withdrawn125%

completed250%

Recent Activity

0 active trials

Showing 4 of 4

terminated

Vagus Nerve Stimulation for Management of Bronchoconstriction in Patients Hospitalized With COPD Exacerbations

NCT01612793

completednot_applicable

Study to Compare (COPD) Assessment Test in COPD Stage III and IV in a Prophylactic Treatment

NCT01679314

withdrawnnot_applicable

Non-Invasive Neurostimulation of the Vagus Nerve With the AlphaCore Device for the Relief of EIB

NCT01923272

completednot_applicable

Prospective Exploratory Study to Assess the Effects of the AlphaCore® Device in Patients With COPD

NCT01720680

Clinical Trials (4)

Showing 4 of 4 trials

NCT01612793

Vagus Nerve Stimulation for Management of Bronchoconstriction in Patients Hospitalized With COPD Exacerbations

Terminated

NCT01679314Not Applicable

Study to Compare (COPD) Assessment Test in COPD Stage III and IV in a Prophylactic Treatment

Completed

NCT01923272Not Applicable

Non-Invasive Neurostimulation of the Vagus Nerve With the AlphaCore Device for the Relief of EIB

Withdrawn

NCT01720680Not Applicable

Prospective Exploratory Study to Assess the Effects of the AlphaCore® Device in Patients With COPD

Completed

All 4 trials loaded

Drug Details

Intervention Type: DEVICE
Total Trials: 4